About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
Press Releases
Menu
Overview
Press Releases
Company Information
Stock Information
SEC Filings
Corporate Governance
Recent Press Releases
Kalytera Completes Deferral Transaction with Former Shareholders of Talent Biotechs
February 8, 2019
Kalytera Reports Additional Positive Data for CBD in Prevention of Acute GVHD
February 5, 2019
Kalytera Announces Change to Scope of Services under Payments Agreements with Salzman Group and Next Share Issuance
January 31, 2019
Kalytera Announces Grant of Stock Options to Certain Directors and Employees
January 28, 2019
Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants
January 22, 2019
Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants
January 15, 2019
Kalytera Announces Initiation of Research Coverage by Echelon Wealth Partners
January 15, 2019
View all News and Insights
Browse by Year
2019
2018
2017
2016
2015
